These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29111262)

  • 1. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.
    Lee JY; Kim MJ; Deliyanti D; Azari MF; Rossello F; Costin A; Ramm G; Stanley EG; Elefanty AG; Wilkinson-Berka JL; Petratos S
    EBioMedicine; 2017 Nov; 25():122-135. PubMed ID: 29111262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelination Delay and Allan-Herndon-Dudley Syndrome Caused by a Novel Mutation in the SLC16A2 Gene.
    La Piana R; Vanasse M; Brais B; Bernard G
    J Child Neurol; 2015 Sep; 30(10):1371-4. PubMed ID: 25380603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorder of thyroid hormone transport into the tissues.
    Groeneweg S; Visser WE; Visser TJ
    Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):241-253. PubMed ID: 28648511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
    Vancamp P; Demeneix BA; Remaud S
    Front Endocrinol (Lausanne); 2020; 11():283. PubMed ID: 32477268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment.
    Zung A; Visser TJ; Uitterlinden AG; Rivadeneira F; Friesema EC
    Eur J Endocrinol; 2011 Nov; 165(5):823-30. PubMed ID: 21896621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered behavioral performance and live imaging of circuit-specific neural deficiencies in a zebrafish model for psychomotor retardation.
    Zada D; Tovin A; Lerer-Goldshtein T; Vatine GD; Appelbaum L
    PLoS Genet; 2014 Sep; 10(9):e1004615. PubMed ID: 25255244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Inhibitors Based on Molecular Docking: Thyroid Hormone Transmembrane Transporter MCT8 as a Target.
    Shaji D
    Curr Drug Discov Technol; 2021; 18(1):105-112. PubMed ID: 31774046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution.
    Kersseboom S; Kremers GJ; Friesema EC; Visser WE; Klootwijk W; Peeters RP; Visser TJ
    Mol Endocrinol; 2013 May; 27(5):801-13. PubMed ID: 23550058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish - An emerging model to explore thyroid hormone transporters and psychomotor retardation.
    Zada D; Blitz E; Appelbaum L
    Mol Cell Endocrinol; 2017 Dec; 459():53-58. PubMed ID: 28274736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of thyroid hormone transporters].
    Braun D
    Nuklearmedizin; 2015; 54(3):77-81. PubMed ID: 26105714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafish.
    Zada D; Tovin A; Lerer-Goldshtein T; Appelbaum L
    Dis Model Mech; 2016 Nov; 9(11):1339-1348. PubMed ID: 27664134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MCT8-specific thyroid hormone cell transporter deficiency: a case report and review of the literature].
    López-Marín L; Martín-Belinchón M; Gutiérrez-Solana LG; Morte-Molina B; Duat-Rodríguez A; Bernal J
    Rev Neurol; 2013 Jun; 56(12):615-22. PubMed ID: 23744248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
    Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
    Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormone transporters and resistance.
    Visser TJ
    Endocr Dev; 2013; 24():1-10. PubMed ID: 23392090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCT8 deficiency in Purkinje cells disrupts embryonic chicken cerebellar development.
    Delbaere J; Vancamp P; Van Herck SL; Bourgeois NM; Green MJ; Wingate RJ; Darras VM
    J Endocrinol; 2017 Feb; 232(2):259-272. PubMed ID: 27879339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation.
    Kobayashi S; Onuma A; Inui T; Wakusawa K; Tanaka S; Shimojima K; Yamamoto T; Haginoya K
    Pediatr Neurol; 2014 Sep; 51(3):414-6. PubMed ID: 25160547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
    Morte B; Gil-Ibañez P; Heuer H; Bernal J
    Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.
    Novara F; Groeneweg S; Freri E; Estienne M; Reho P; Matricardi S; Castellotti B; Visser WE; Zuffardi O; Visser TJ
    Hum Mutat; 2017 Mar; 38(3):260-264. PubMed ID: 27805744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
    Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
    Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.